Dual-Function Adjuvant Cyclosporin A: Enhancing RSV-Specific Humoral Immunity via Treg-Driven B-Cell Activation
CsA demonstrates dual adjuvant properties by enhancing RSV-specific neutralizing IgG titers through Treg-driven B-cell activation, offering a potential strategy to optimize vaccine-induced humoral immunity.
Authors
- Caixia Su (ORCID: https://orcid.org/0000-0002-7216-7649)
- Yiwei Zhong
- Bin Wang (ORCID: https://orcid.org/0000-0002-9945-1818)
- Chaofan Li (ORCID: https://orcid.org/0000-0002-5426-1498)
- Gan Zhao
- Shuren Zhang (ORCID: https://orcid.org/0000-0002-9384-1786)
Institutions
- Shanghai Medical College of Fudan University (CN)
- Suzhou Vocational Health College (CN)
- Children's Hospital of Fudan University (CN)
Publication Details
- Journal
- Vaccines
- Published
- 2025-09-23
- DOI
- https://doi.org/10.3390/vaccines13100997
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Science and Technology of the People's Republic of China
- Fudan University